Anti-Biofilm Properties of <i>Saccharomyces cerevisiae </i>CNCM I-3856 and <i>Lacticaseibacillus rhamnosus </i>ATCC 53103 Probiotics against <i>G. vaginalis</i>

by Samuele Sabbatini, Claudia Monari, Nathalie Ballet, Amélie Cayzeele Decherf, Silvia Bozza, Barbara Camilloni, Stefano Perito, Anna Vecchiarelli
Published 2020-08-01

Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis

by Samuele Sabbatini, Claudia Monari, Nathalie Ballet, Paolo Mosci, Amélie Cayzeele Decherf, Fanny Pélerin, Stefano Perito, Paolo Scarpelli, Anna Vecchiarelli
Published 2018-12-01

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

by Elena Roselletti, Samuele Sabbatini, Nathalie Ballet, Stefano Perito, Eva Pericolini, Elisabetta Blasi, Paolo Mosci, Amélie Cayzeele Decherf, Claudia Monari, Anna Vecchiarelli
Published 2019-07-01

Spatial and temporal modulation of enterotoxigenic E. coli H10407 pathogenesis and interplay with microbiota in human gut models

by Charlène Roussel, Kim De Paepe, Wessam Galia, Jana De Bodt, Sandrine Chalancon, Françoise Leriche, Nathalie Ballet, Sylvain Denis, Monique Alric, Tom Van de Wiele, Stéphanie Blanquet-Diot
Published 2020-10-01

Multi-targeted properties of the probiotic saccharomyces cerevisiae CNCM I-3856 against enterotoxigenic escherichia coli (ETEC) H10407 pathogenesis across human gut models

by Charlène Roussel, Kim De Paepe, Wessam Galia, Jana de Bodt, Sandrine Chalancon, Sylvain Denis, Françoise Leriche, Pascal Vandekerkove, Nathalie Ballet, Stéphanie Blanquet-Diot, Tom Van de Wiele
Published 2021-01-01